FDA On the Fence About OTC Birth Control
The US Food and Drug Administration (FDA) recently met to discuss whether to approve Opill, Perrigo’s hormonal contraceptive, for over-the-counter (OTC) use. Although reproductive rights advocates contend that the move would expand access to contraceptives to people who don’t have a primary care clinician, some religious advocates and committee members argued against it.
HRA Pharma Files FDA Application for First Over-the-Counter Oral Contraceptive
HRA Pharma has submitted its application for the US’s first over-the-counter (OTC) birth control pill. The company, a subsidiary of [...]
Abortion Draft Opinion Reignites Push for Over-the-counter Birth Control
The leaked US Supreme Court draft opinion on abortion rights has spurred additional urgency in efforts to gain FDA approval [...]
Advertisement
